Morgan Stanley analyst Erin Wright raised the firm’s price target on McKesson (MCK) to $642 from $612 and keeps an Overweight rating on the shares, which has been named “Top Pick” in its group, replacing UnitedHealth (UNH). Diversified Managed Care “woefully underperformed” in 2024 and while uncertainty is pressuring sentiment, the firm sees “opportunities in a friendlier policy backdrop,” the analyst tells investors in a 2025 outlook note on the healthcare services group. Drug distributors “have rightfully been viewed as relative safe havens” and the firm thinks stocks in the group can continue to “grind higher,” the analyst added.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MCK:
- McKesson price target raised to $641 from $535 at Wells Fargo
- Cardinal Health assumed with an Outperform at Mizuho
- McKesson assumed with a Neutral at Mizuho
- Lone Pine takes new positions in Salesforce and Starbucks, exits Mastercard
- McKesson price target raised to $713 from $630 at Citi
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
